INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 21, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 683 | $577.37 | 307,849 |
| Aug 02, 2021 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 5 | $577.42 | 23,461 |
| Nov 02, 2015 |
Director, President Regeneron Laboratori
Trans History: 617
|
Director, President Regeneron Laboratori | Form 4 | Open market or private sale of non-derivative or derivative security | 1,996 | $577.58 | 545,516 |
| Sep 01, 2022 |
EVP Commercial
Trans History: 139
|
EVP Commercial | Form 4 | Open market or private sale of non-derivative or derivative security | 1,100 | $577.62 | 19,644 |
| Aug 14, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Open market or private sale of non-derivative or derivative security | 2,258 | $577.75 | 17,321 |
| May 28, 2020 |
Director
Trans History: 320
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $578.00 | 8,200 |
| Sep 06, 2022 |
Director
Trans History: 48
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 273 | $578.25 | 6,020 |
| May 21, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $578.34 | 307,749 |
| Sep 06, 2022 |
Director
Trans History: 524
|
Director | Form 4 | Open market or private sale of non-derivative or derivative security | 11 | $578.56 | 19,664 |
| Aug 14, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Open market or private sale of non-derivative or derivative security | 1,500 | $578.63 | 15,821 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.